Lyell Immunopharma, Inc. (LYEL)
21.21
+0.40
(+1.92%)
USD |
NASDAQ |
Apr 02, 16:00
21.21
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Market Cap : 320.12M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 109.28B |
| Fortress Biotech, Inc. | 84.85M |
| Oramed Pharmaceuticals, Inc. | 139.55M |
| Climb Bio, Inc. | 295.77M |
| Moderna, Inc. | 19.20B |
Market Cap Related Metrics
| PS Ratio | 52454.48 |
| Price to Book Value | 1.290 |
| Price | 21.21 |
| Earnings Yield | -54.63% |